HOSPItal Use of Paliperidone Palmitate - A Prospective Non-Interventional Study
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2018
Price : $35 *
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Acronyms HOSPIPalm
- Sponsors Janssen-Cilag
- 07 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 17 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 07 Mar 2014 Planned End Date changed from 1 May 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov record.